KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Vuzix (VUZI) Asset Writedowns and Impairment (2016 - 2024)

Vuzix has reported Asset Writedowns and Impairment over the past 10 years, most recently at -$540000.0 for Q4 2024.

For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to -$540000.0; the TTM value through Dec 2024 reached -$265796.0, down 734.81%, while the annual FY2023 figure was $41869.0, 57.13% down from the prior year.
Asset Writedowns and Impairment for Q4 2024 was -$540000.0 at Vuzix, down from $250000.0 in the prior quarter.
Over five years, Asset Writedowns and Impairment peaked at $250000.0 in Q3 2024 and troughed at -$540000.0 in Q4 2024.